More on AAPG

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/20/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Ascentage Pharma (NQ:AAPG)
Delayed: 23.14 +0.83 (3.72%)
Prev. Close $22.31  
Open$23.14 
52 Wk High$ 
52 Wk Low$ 
Day High$23.14 
Day Low$23.14 
P/E N/A  
EPS$ 
Volume375 

Friends, Peers and Foes (?): 36X AAPG.V (more...)

Feb 9, 2026 08:00 AM Ascentage Pharma to Participate in Guggenheim Emerging Outlook: Biotech Summit 2026
Feb 5, 2026 06:30 PM Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Feb 5, 2026 06:30 PM Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288
Jan 14, 2026 08:25 PM Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Jan 13, 2026 07:19 AM Rodman & Renshaw Starts Ascentage Pharma Group (AAPG) at Buy
Dec 17, 2025 08:00 AM Ascentage Pharma to Present at 44th Annual J.P. Morgan Healthcare Conference
Dec 9, 2025 06:06 AM Ascentage Pharma presents four-year data on leukemia drug olverembatinib
Dec 9, 2025 06:06 AM Ascentage Pharma reports phase III data for leukemia drug candidate
Dec 9, 2025 06:06 AM Ascentage Pharma reports updated trial data for blood cancer drug
Dec 8, 2025 07:45 PM ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encouraging Potential for Early-Line Treatment
View All Articles

Entities mentioned with AAPG

View All Entities